Skip to main content
SpringerLink
Log in

Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, et al. Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans. Eur J Nucl Med Mol Imaging. 2016;43:1105–1114. doi:10.1007/s00259-015-3276-2.

    Article  PubMed  Google Scholar 

  2. Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?. J Nucl Med. 2006;47:393–403.

    PubMed  Google Scholar 

  3. Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI, et al. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med. 2012;53:1367–1374. doi:10.2967/jnumed.112.103325.

    Article  CAS  PubMed  Google Scholar 

  4. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205–212.

    CAS  PubMed  Google Scholar 

  5. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res Rev. 1982;4:237–274. doi:10.1016/0165-0173(82)90018-2.

    Article  CAS  Google Scholar 

  6. Sokoloff L, Reivich M, Kennedy C, Des Rosiers M, Patlak C, Pettigrew K, et al. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977; 28: 897–916. doi:10.1111/j.1471-4159.1977.tb10649.x.

    Article  CAS  PubMed  Google Scholar 

  7. Valentina G, Silvia M, Marco P. Dual-phase amyloid PET: hitting two birds with one stone. Eur J Nucl Med Mol Imaging. 2016;43:1300–1303. doi:10.1007/s00259-016-3393-6.

    Article  PubMed  Google Scholar 

  8. Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T. Correlation of L-methyl- 11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas. J Neurooncol. 2010; 99: 217–225. doi:10.1007/s11060-010-0117-9.

    Article  CAS  PubMed  Google Scholar 

  9. Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, et al. Comparison of 11C-methionine, 11C-choline, and 18F-fluorodeoxyglucose-positron emission tomography for distinguishing glioma recurrence from radiation necrosis. Neurol Med Chir (Tokyo). 2014;54: 280–289. doi:10.2176/nmc.oa2013-0117.

    Article  Google Scholar 

  10. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49: 694–699.

    Article  PubMed  Google Scholar 

  11. Stöber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl- 3H] methionine (MET) and O-(2-[18F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging. 2006; 33:932–939.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan

    Masashi Kameyama

  2. Division of Nuclear Medicine, Department of Radiology, School of Medicine, Keio University, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Masashi Kameyama

  3. Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan

    Masashi Kameyama

  4. Department of Geriatric Medicine, School of Medicine, The University of Tokyo, 7-3-1 Hongo, 113-8655, Bunkyo-ku, Tokyo, Japan

    Yumi Umeda-Kameyama

Authors
  1. Masashi Kameyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yumi Umeda-Kameyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masashi Kameyama.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Sources of support: Grants-in-Aid for Scientific Research, 26460902 to Yumi Umeda-Kameyama.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kameyama, M., Umeda-Kameyama, Y. Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET). Eur J Nucl Med Mol Imaging 43, 2267–2268 (2016). https://doi.org/10.1007/s00259-016-3470-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-016-3470-x

Keywords

Search

Navigation